Exact Mass: 400.2546

Exact Mass Matches: 400.2546

Found 428 metabolites which its exact mass value is equals to given mass value 400.2546, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ophiobolin A

(+)-Ophiobolin A

C25H36O4 (400.2613)

16alpha,17-Isopropylidenedioxy-6alpha-methylprogesterone

16alpha,17-Isopropylidenedioxy-6alpha-methylprogesterone; 16alpha,17-Dihydroxy-6alpha-methylpregn-4-ene-3,20-dione cyclic acetal with acetone

C25H36O4 (400.2613)

Atractyloside C

C21H36O7 (400.2461)

11'-Carboxy-gamma-tocotrienol

(4E,8E)-11-[(2R)-6-hydroxy-2,7,8-trimethyl-3,4-dihydro-2H-1-benzopyran-2-yl]-4,8-dimethylundeca-4,8-dienoic acid

C25H36O4 (400.2613)

11-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 11-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. Gamma-tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. Gamma-tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. 11-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 11-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate

Colupulone

5-hydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohex-4-ene-1,3-dione

C25H36O4 (400.2613)

Colupulone is found in alcoholic beverages. Colupulone is a constituent of the resin of English hops

Ajulemic acid

1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,10H,10aH-benzo[c]isochromene-9-carboxylic acid

C25H36O4 (400.2613)

Cochliobolin A

14-hydroxy-3,3,14-trimethyl-5-(2-methylprop-1-en-1-yl)-12-oxospiro[oxolane-2,6-tricyclo[9.3.0.0³,⁷]tetradecan]-9-ene-10-carbaldehyde

C25H36O4 (400.2613)

(6Ar,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,9,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid

C25H36O4 (400.2613)

MG(5-iso PGF2VI/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoic acid

C21H36O7 (400.2461)

MG(5-iso PGF2VI/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/5-iso PGF2VI/0:0)

1,3-Dihydroxypropan-2-yl (3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoic acid

C21H36O7 (400.2461)

MG(0:0/5-iso PGF2VI/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

feigrisolide C

(2S,3S,6R,8R)-Homononactoyl-(2R,3R,6S,S)-nonactic acid

C21H36O7 (400.2461)

A sesterterpenoid isolated from the marine sponge Aplysinopsis digitata that exhibits cytotoxicity against P388 mouse leukemia cells.

Pumilaside C

C21H36O7 (400.2461)

OLEIFERINONE

C25H36O4 (400.2613)

Aeginetin

(5R,6R)-5,6-Dihydro-5,6-dihydroxy-12-apo-beta,psi-carotenoic acid

C25H36O4 (400.2613)

Cacospongionolide E

C25H36O4 (400.2613)

Kuguacin L

C25H36O4 (400.2613)

Liriopeoside A

C21H36O7 (400.2461)

Isocyclocitrinol B

C25H36O4 (400.2613)

Fusarielin D

C25H36O4 (400.2613)

Actinopyrone A

C25H36O4 (400.2613)

Neocyclocitrinol D

C25H36O4 (400.2613)

Pterodontoside H

C21H36O7 (400.2461)

Astakolactin

C25H36O4 (400.2613)

3alpha-angeloyloxy-4-epi-daniellol

C25H36O4 (400.2613)

Pumilaside B

C21H36O7 (400.2461)

Cyclocitrinol

C25H36O4 (400.2613)

(-)-Phenazinomycin

C27H32N2O (400.2515)

Acantholide B

(-)-Acantholide B

C25H36O4 (400.2613)

23,24,25,26,27-Pentanor-3,7-dioxocucurbit-5-en-22-oic acid

C25H36O4 (400.2613)

Bonactin

C21H36O7 (400.2461)

10-O-beta-D-glucopyranosideoplopanone|oplopanone-8-O-beta-D-glucopyranoside

C21H36O7 (400.2461)

ophiobolin J

C25H36O4 (400.2613)

18-Angeloyl 鈥樎?ent-3beta,4alphaH)-15,16-Epoxy-7,13(16),14-clerodatriene-3,18-diol

C25H36O4 (400.2613)

1-O-isopropyl-6-O-(5,9-dimethyl-2,8-decadienoyl)-beta-D-glucopyranoside|citrusoside A

C21H36O7 (400.2461)

Solidagolactone III

C25H36O4 (400.2613)

[(1R,3R,4R,4aS,8aR)-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2H-furan-3-yl)ethyl]-1,2,3,4a,5,6-hexahydronaphthalen-1-yl] (E)-2-methylbut-2-enoate is a natural product found in Solidago virgaurea with data available.

Cacospongionolide B

C25H36O4 (400.2613)

ent-3beta-(3-methyl-2-butenoyloxy)-15-beyeren-19-oic acid

C25H36O4 (400.2613)

elasclepic acid|ent-14beta-tygloyloxybeyer-15-ene-19-oic acid

C25H36O4 (400.2613)

C21H36O7

C21H36O7 (400.2461)

C25H36O4

C25H36O4 (400.2613)

ent-18-angeloyloxykaur-16-en-19-oic acid

C25H36O4 (400.2613)

15alpha-angeloyloxykaur-16-en-19-oic acid|15alpha-tiglinoyloxy-ent-kaurenic acid|15alpha-tiglinoyloxy-ent-kaurenoic acid|15alpha-tigloyloxy-ent-kaur-16-en-19-oic acid

C25H36O4 (400.2613)

24-Methyl-25-nor-12,24-dioxo-16-scalaren-22-oic acid

C25H36O4 (400.2613)

1(R),4beta-dihydroxy-trans-eudesm-6-ene-1-O-beta-D-glucopyranoside

C21H36O7 (400.2461)

3beta,11-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside A

C21H36O7 (400.2461)

5-[13-(3-Furanyl)-2, 6, 10-trimethyl-3, 5-tridecadienyl]-4-hydroxy-3-methyl-2(5H)-furanone|7,8-Dihydroisopalinurin

C25H36O4 (400.2613)

79406-09-0

C25H36O4 (400.2613)

(+)-20-formylhyrtiosal

C25H36O4 (400.2613)

Luffariolide E

C25H36O4 (400.2613)

4-(linoleoyloxy)benzoic acid

C25H36O4 (400.2613)

leucosceptroid B

C25H36O4 (400.2613)

3beta-[(beta-D-glucopyranosyl)oxy]eudesm-4(14)-en-11-ol

C21H36O7 (400.2461)

18-succinyloxyabieta-8,11,13-triene methyl ester

C25H36O4 (400.2613)

13alpha-Angeloyloxy-atisirensaeure

C25H36O4 (400.2613)

15alpha-senecioyloxy-ent-kaurenic acid|ent-15beta-senecioyloxy-kaur-16-en-19-oic acid

C25H36O4 (400.2613)

luffarin-M

C25H36O4 (400.2613)

luffarin-F

C25H36O4 (400.2613)

NCGC00385238-01

C25H36O4 (400.2613)

7-senecioxycleistanth-13,15-dien-18-oic acid

C25H36O4 (400.2613)

ent-3beta-Angeloyloxy-16beta,17-epoxy-19-kauranal

C25H36O4 (400.2613)

Oohiobolin D

C25H36O4 (400.2613)

(ent-15beta)-Angeloyl-15-Hydroxy-16-kauren-19-oic acid|(ent-15beta)-Tigloyl-15-Hydroxy-16-kauren-19-oic acid|Angeloyl-15-Hydroxy-16-kauren-19-oic acid|Tigloyl-15-Hydroxy-16-kauren-19-oic acid

C25H36O4 (400.2613)

C27H32N2O

C27H32N2O (400.2515)

1alpha,6beta-dihydroxy-5,10-bis-epi-eudesm-4(15)-ene-6-O-beta-D-glucopyranoside|funingensin A

C21H36O7 (400.2461)

7-drimen-3beta-,11-diol 3-O-beta-D-glucopyranoside

C21H36O7 (400.2461)

3alpha-hydroxypatchoulol 3-O-beta-D-glucopyranoside

C21H36O7 (400.2461)

15-hydroxypatchoulol 15-O-beta-D-glucopyranoside

C21H36O7 (400.2461)

14-[((2Z)-2-methylbut-2-enoyl)oxy]-3,4-seco-ent-kaura-4(19),16-dien-3-oic acid

C25H36O4 (400.2613)

3,7,12,24-Tetraoxohomocholan

C25H36O4 (400.2613)

(2R,5S,7R,10S)-7-hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane

(2R*,5S*,7R*,10S*)-7-hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane

C21H36O7 (400.2461)

15-hydroxy-a-eudesmol-11-O-beta-D-glucopyranoside

C21H36O7 (400.2461)

3beta,19-diacetoxypregna-5,20-diene|sclerosteroid B

C25H36O4 (400.2613)

1beta-hydroxy-3-oxo-4beta,5alpha,7alpha-H-eudesmane 11-O-alpha-L-rhamnopyranoside

C21H36O7 (400.2461)

7beta-angeloxy-ent-kaur-16-en-19-oic acid

C25H36O4 (400.2613)

acantholide B|thorectidaeolide B

C25H36O4 (400.2613)

bisabolol oxide A beta-D-glucoside

C21H36O7 (400.2461)

phorbaketal B

C25H36O4 (400.2613)

2,7,11-trihydroxybisabola-1(15),9-diene 7-beta-D-fucopyranoside

C21H36O7 (400.2461)

thorectidaeolide A

C25H36O4 (400.2613)

(3beta,5beta,14beta,16beta,20Z)-16-acetoxy-14,21-epoxy-24-norcholan-20,22-dien-3-ol

C25H36O4 (400.2613)

2,7,10-trihydroxybisabola-1(15),11-diene 7-beta-D-fucopyranoside

C21H36O7 (400.2461)

nakijiquinone S

C25H36O4 (400.2613)

methyl 3,6-dioxochol-4-en-24-oate

C25H36O4 (400.2613)

19-Carboxylic acid,3-(3-methyl-2-butenoyl)-(ent-3beta)-16-Kaurene-3,19-diol

C25H36O4 (400.2613)

(5S,6E)-5-beta-D-glucopyranosyloxy-3-hydroxy-3,7,11-trimethyldodeca-1,6,10-triene|amarantholidoside III

C21H36O7 (400.2461)

gummiferolic acid|Gummiferolic-saeure

C25H36O4 (400.2613)

3beta,11-dihydroxy-drim-8(12)-en-3-O-beta-D-glucopyranoside|xianglinmaojueside B

C21H36O7 (400.2461)

3alpha,16beta-dihydroxy-5alpha-pregna-1,20-diene 3,16-diacetate|Di-Ac-Pregna-1,20-diene-3,16-diol

C25H36O4 (400.2613)

ent-12alpha-angeloxykaur-16-en-19-oic acid

C25H36O4 (400.2613)

(ent-15alpha)-3-Methyl-2-butenoyl-15-Hydroxy-16-kauren-19-oic acid|15-Hydroxy-16-kauren-19-oic acid3-Methyl-2-butenoyl

C25H36O4 (400.2613)

cacospongionolide

C25H36O4 (400.2613)

Periforgenin A

C25H36O4 (400.2613)

1beta-(beta-D-glucopyranosyl)oxy-6alpha-hydroxyeudesman-4(15)-ene|1??-D-Glucopyranosyloxy-6??-hydroxyeudesman-4(15)-ene

C21H36O7 (400.2461)

3beta-hydroxyelasclepial

C25H36O4 (400.2613)

1(R),4beta-dihydroxy-trans-eudesm-7-ene-1-O-beta-D-glucopyranoside|oplodiol 1-O-beta-D-glucopyranoside

C21H36O7 (400.2461)

5-Deoxy-5-oxoerythronolid B

C21H36O7 (400.2461)

5-<13-(furan-3-yl)-2,6,10-trimethyltrideca-6,8-dienyl>-4-hydroxy-3-methylfuran-2(5H)-one|5-[13-(3-Furanyl)-2, 6, 10-trimethyl-6, 8-tridecadienyl]-4-hydroxy-3-methyl-2(5H)-furanone|5-[13-(furan-3-yl)-2,6,10-trimethyltrideca-6,8-dienyl]-4-hydroxy-3-methylfuran-2(5H)-one

5-<13-(furan-3-yl)-2,6,10-trimethyltrideca-6,8-dienyl>-4-hydroxy-3-methylfuran-2(5H)-one|5-[13-(3-Furanyl)-2, 6, 10-trimethyl-6, 8-tridecadienyl]-4-hydroxy-3-methyl-2(5H)-furanone|5-[13-(furan-3-yl)-2,6,10-trimethyltrideca-6,8-dienyl]-4-hydroxy-3-methylfuran-2(5H)-one

C25H36O4 (400.2613)

Metachromin F

C25H36O4 (400.2613)

ximaosteroid C

3beta,6alpha-dihydroxy-pregn-1,20-dien-3,6-diacetate

C25H36O4 (400.2613)

18-Senecionyloxy-ent-kaurensaeure|3-Methyl-2-butenoyl-ent-18-Hydroxy-16-kauren-19-oic acid

C25H36O4 (400.2613)

3alpha-hydroxy-18-angeloyloxy-13-furyl-ent-labda-8(17)-ene

C25H36O4 (400.2613)

3alpha-angeloyloxy-15,16-epoxycleistanth-12-en-11-one

C25H36O4 (400.2613)

11,14-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside C

C21H36O7 (400.2461)

Litophytolide B

C25H36O4 (400.2613)

syringenin-4-O-farneosylether

C25H36O4 (400.2613)

plucheoside E

C21H36O7 (400.2461)

Colupulone

2,4-CYCLOHEXADIEN-1-ONE, 3,5-DIHYDROXY-4,6,6-TRIS(3-METHYL-2-BUTEN-1-YL)-2-(2-METHYL-1-OXOPROPYL)-

C25H36O4 (400.2613)

Colupulone is a beta-bitter acid in which the acyl group is specified as isobutanoyl. It is a conjugate acid of a colupulone(1-). Colupulone is a natural product found in Humulus lupulus with data available. A beta-bitter acid in which the acyl group is specified as isobutanoyl.

Strobilinin

C25H36O4 (400.2613)

Solidagolactone II

C25H36O4 (400.2613)

Elongatolide C is a natural product found in Solidago virgaurea with data available.

2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid

NCGC00180835-03!2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid

C21H36O7 (400.2461)

C25H36O4

NCGC00385238-01_C25H36O4_

C25H36O4 (400.2613)

2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000846078]

NCGC00180835-03!2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000846078]

C21H36O7 (400.2461)

Colupulone isomer (MSe)

C25H36O4 (400.2613)

2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]

NCGC00180835-03!2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]

C21H36O7 (400.2461)

Ophiobolin P

C25H36O4 (400.2613)

Ophiobolin Q

C25H36O4 (400.2613)

Jambone B

C25H36O4 (400.2613)

1-eicosanyl sulfate sodium salt

C20H41NaO4S (400.2623)

2,2,2,2-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetamide

C16H32N8O4 (400.2546)

ent-3β-Tigloyloxykaur-16-en-19-oic acid

C25H36O4 (400.2613)

Bis[4-(vinyloxy)butyl] 1,6-hexanediylbiscarbamate

C20H36N2O6 (400.2573)

sodium 2-octyldodecyl sulphate

C20H41NaO4S (400.2623)

Lenabasum

Ajulemic acid

C25H36O4 (400.2613)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063386 - Cannabinoid Receptor Agonists C308 - Immunotherapeutic Agent

Dehydrosimvastatin

C25H36O4 (400.2613)

(1R,2S,3S,3S,4R,7S,8E,11R)-4-hydroxy-1,3,4-trimethyl-5-(2-methylprop-1-enyl)-6-oxospiro[oxolane-2,12-tricyclo[9.3.0.03,7]tetradec-8-ene]-8-carbaldehyde

C25H36O4 (400.2613)

Cochliobolin A

C25H36O4 (400.2613)

MG(5-iso PGF2VI/0:0/0:0)

C21H36O7 (400.2461)

MG(0:0/5-iso PGF2VI/0:0)

C21H36O7 (400.2461)

(6Ar,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,9,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid

C25H36O4 (400.2613)

Rapivab

C15H36N4O8 (400.2533)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AH - Neuraminidase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004791 - Enzyme Inhibitors

(15S)-15alpha-(3-Methyl-2-butenoyloxy)kaur-16-en-18-oic acid

C25H36O4 (400.2613)

Citrusoside A

C21H36O7 (400.2461)

A natural product found in Citrus hystrix.

2-[(1E,5E,7E,9R,10R,11E)-10-hydroxy-3,7,9,11-tetramethyltrideca-1,5,7,11-tetraenyl]-6-methoxy-3,5-dimethylpyran-4-one

C25H36O4 (400.2613)

Asperterpenoid B

C25H36O4 (400.2613)

2,4-dioxo-3-pentyl-N-[3-(1-piperidinyl)propyl]-1H-quinazoline-7-carboxamide

C22H32N4O3 (400.2474)

rel-(2R,5S,7R,10S)-7-Hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane

C21H36O7 (400.2461)

A natural product found in Carthamus oxyacantha.

2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone

C22H32N4O3 (400.2474)

2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone

C22H32N4O3 (400.2474)

(3R)-farnesyl-6-hydroxy-2,3,5-trimethyl-4-oxocyclohexa-1,5-diene-1-carboxylic acid

C25H36O4 (400.2613)

A sesterterpenoid that is 4-oxocyclohexa-1,5-diene-1-carboxylic acid carrying three additional methyl substituents at positions 2, 3 and 5 as well as farnsyl and hydroxy substituents at positions 3 and 6 respectively. An intermediate in the biosynthesis of terretonin.

Fahfa 25:6

C25H36O4 (400.2613)

11-Carboxy-gamma-tocotrienol

C25H36O4 (400.2613)

PM050463

C25H36O4 (400.2613)

A natural product found in Streptomyces albus.

FAHFA 10:1/O-15:5

C25H36O4 (400.2613)

FAHFA 10:2/O-15:4

C25H36O4 (400.2613)

FAHFA 10:3/O-15:3

C25H36O4 (400.2613)

FAHFA 11:2/O-14:4

C25H36O4 (400.2613)

FAHFA 11:3/O-14:3

C25H36O4 (400.2613)

FAHFA 12:2/O-13:4

C25H36O4 (400.2613)

FAHFA 12:3/O-13:3

C25H36O4 (400.2613)

FAHFA 12:4/O-13:2

C25H36O4 (400.2613)

FAHFA 13:2/O-12:4

C25H36O4 (400.2613)

FAHFA 13:3/O-12:3

C25H36O4 (400.2613)

FAHFA 13:4/O-12:2

C25H36O4 (400.2613)

FAHFA 14:3/O-11:3

C25H36O4 (400.2613)

FAHFA 14:4/O-11:2

C25H36O4 (400.2613)

FAHFA 15:3/O-10:3

C25H36O4 (400.2613)

FAHFA 15:4/O-10:2

C25H36O4 (400.2613)

FAHFA 15:5/O-10:1

C25H36O4 (400.2613)

FAHFA 16:3/O-9:3

C25H36O4 (400.2613)

FAHFA 16:4/O-9:2

C25H36O4 (400.2613)

FAHFA 16:5/O-9:1

C25H36O4 (400.2613)

FAHFA 17:4/O-8:2

C25H36O4 (400.2613)

FAHFA 17:5/O-8:1

C25H36O4 (400.2613)

FAHFA 25:6;O

C25H36O4 (400.2613)

FAHFA 8:1/O-17:5

C25H36O4 (400.2613)

FAHFA 8:2/O-17:4

C25H36O4 (400.2613)

FAHFA 9:1/O-16:5

C25H36O4 (400.2613)

FAHFA 9:2/O-16:4

C25H36O4 (400.2613)

FAHFA 9:3/O-16:3

C25H36O4 (400.2613)

ST 21:0;O7

C21H36O7 (400.2461)

ST 25:4;O4

C25H36O4 (400.2613)

4-[(2r)-5-{2-[(1s,2s,8ar)-1,2,5,5-tetramethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5-hydroxy-5h-furan-2-one

C25H36O4 (400.2613)

2-[(5-hydroxy-2-isopropyl-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C21H36O7 (400.2461)

(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxypropyl]oxolan-2-yl]propanoyl]oxy}butyl]oxolan-2-yl]propanoic acid

C21H36O7 (400.2461)

(5s)-4-[(3e,7e)-4,8-dimethyl-10-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5-hydroxy-5h-furan-2-one

C25H36O4 (400.2613)

5,9-dimethyl-6-[(2-methylbut-2-enoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H36O4 (400.2613)

(5r)-4-[(2s)-5-{2-[(1r,2r,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5-hydroxy-5h-furan-2-one

C25H36O4 (400.2613)

5-hydroxy-4-{5-[2-(1,2,5,5-tetramethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl)ethyl]-3,6-dihydro-2h-pyran-2-yl}-5h-furan-2-one

C25H36O4 (400.2613)

(1e)-2-[(1s,2r,3s,9s)-3,9-dimethyl-3-(4-methylpent-3-en-1-yl)-8,12-dioxatricyclo[7.2.1.0¹,⁶]dodec-5-en-2-yl]ethenyl 3-methylbut-2-enoate

C25H36O4 (400.2613)

(5r)-5-[(2r,5e,9e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-5,9-dien-1-yl]-4-hydroxy-3-methyl-5h-furan-2-one

C25H36O4 (400.2613)

(2r,5s,6s,9r,13s,15r)-6-[(2r,3r,4e)-2,3-dihydroxyhex-4-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one

C25H36O4 (400.2613)

(2s,3r,4s,5r,6r)-2-({2-[(2r,5r,7r,10r)-7-hydroperoxy-10-methyl-6-methylidenespiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol

C21H36O7 (400.2461)

(1'r,2s,3s,3'r,5r,7'r,9's,10'e)-9'-hydroxy-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-10',13'-dien-12'-one

C25H36O4 (400.2613)

(3s,4s,7z)-7-[(4e,8e)-11-(furan-3-yl)-4,8-dimethylundeca-4,8-dien-1-ylidene]-4-hydroxy-3-methyloxocan-2-one

C25H36O4 (400.2613)

5-hydroxy-4-[(1e)-5-hydroxy-4-[4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]penta-1,3-dien-1-yl]-5h-furan-2-one

C25H36O4 (400.2613)

2-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-4-[3-(hydroxymethyl)-5-oxo-2h-furan-2-yl]but-2-enal

C25H36O4 (400.2613)

4-hydroxy-6-methyl-7-(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)-3-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione

C25H36O4 (400.2613)

(2r,3s,4e,6e)-7-[(1ar,2r,3s,3as,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-1a,6-dimethyl-2h,3h,3ah,4h,7h,7ah,7bh-naphtho[1,2-b]oxiren-3-yl]-3-hydroxy-2,4-dimethylhepta-4,6-dienoic acid

C25H36O4 (400.2613)

9-methyl-5-{[(2-methylbut-2-enoyl)oxy]methyl}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H36O4 (400.2613)

(1r,2s,3as,3bs,5as,7s,9ar,9bs,11as)-7-(acetyloxy)-1-ethenyl-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate

C25H36O4 (400.2613)

(1s,4s,5r,9s,10r,12r,13r)-5,9-dimethyl-12-{[(2z)-2-methylbut-2-enoyl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H36O4 (400.2613)

3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-1,2,3,4a,5,6-hexahydronaphthalen-1-yl 2-methylbut-2-enoate

C25H36O4 (400.2613)

(5r)-4-[(2r)-5-{2-[(1as,4ar,5s,6s,8as)-1a,5,6-trimethyl-octahydrocyclopropa[e]naphthalen-5-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5-hydroxy-5h-furan-2-one

C25H36O4 (400.2613)

(2r,5r,6r,9r,13s,15r)-6-[(2e,4r,5r)-4,5-dihydroxyhex-2-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one

C25H36O4 (400.2613)

(2r,5s,9r,13s,15s)-6-[(3e,5s)-2,5-dihydroxyhex-3-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one

C25H36O4 (400.2613)

2-(hydroxymethyl)-6-{[5-(hydroxymethyl)-1,1,4a-trimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl]oxy}oxane-3,4,5-triol

C21H36O7 (400.2461)

(1s,2s,3e,5r,7e,11r)-8-(hydroxymethyl)-1,5-dimethyl-5-[(2e)-4-methylpenta-2,4-dien-1-yl]-12-oxabicyclo[9.1.0]dodeca-3,7-dien-2-yl 3-methylbut-2-enoate

C25H36O4 (400.2613)

(1'r,2s,3s,3'r,5r,7'r,10'z)-5-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]-10'-(hydroxymethyl)-3,3',14'-trimethylspiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-10',13'-dien-12'-one

C25H36O4 (400.2613)

(2r,3r,4s,5r,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-4,8a-dimethyl-6-(propan-2-ylidene)-hexahydro-1h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H36O7 (400.2461)

(1s,2r,4as,5r,8as)-5-[2-(furan-3-yl)ethyl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate

C25H36O4 (400.2613)

4-[(7e)-4,8-dimethyl-10-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5-hydroxy-5h-furan-2-one

C25H36O4 (400.2613)

5-hydroxy-4-{5-hydroxy-4-[4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]penta-1,3-dien-1-yl}-5h-furan-2-one

C25H36O4 (400.2613)

(4s,5r,9s,10s,13s,15s)-5,9-dimethyl-15-{[(2z)-2-methylbut-2-enoyl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H36O4 (400.2613)

(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxybutyl]oxolan-2-yl]propanoyl]oxy}propyl]oxolan-2-yl]propanoic acid

C21H36O7 (400.2461)

(5r)-4-[(2r)-5-{2-[(1s,2s,8ar)-1,2,5,5-tetramethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5-hydroxy-5h-furan-2-one

C25H36O4 (400.2613)

(1r,3s,7r,8e,11s,12r)-12-[(2s,3z,5s)-5,6-dihydroxy-6-methylhept-3-en-2-yl]-1,4-dimethyl-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde

C25H36O4 (400.2613)

(2r,5s,6s,9r,13s,15r)-6-[(2r,3s,4e)-2,3-dihydroxyhex-4-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one

C25H36O4 (400.2613)

(2r,3r,4s,5s,6r)-2-{[(1ar,3as,4s,7s,7as,7br)-7-hydroxy-1,1,3a,7-tetramethyl-octahydrocyclopropa[a]naphthalen-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H36O7 (400.2461)

(2r,5s,6s,9r,13s,15s)-6-[(2s,3e,5r)-2,5-dihydroxyhex-3-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one

C25H36O4 (400.2613)

(1s,4s,5s,6r,9s,10r,13r)-5,9-dimethyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H36O4 (400.2613)

5,9,13-trimethyl-16-[(2-methylbut-2-enoyl)oxy]tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-ene-5-carboxylic acid

C25H36O4 (400.2613)

(2s,3r,4s,5s,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-1,4a-dimethyl-7-(propan-2-ylidene)-hexahydro-2h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H36O7 (400.2461)

2-[(3r)-3-hydroxy-3-(5-oxo-2h-furan-3-yl)propylidene]-6-methyl-8-(2,6,6-trimethylcyclohex-1-en-1-yl)oct-5-enal

C25H36O4 (400.2613)

(2s,3r,4s,5r,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-1,4a-dimethyl-7-(propan-2-ylidene)-hexahydro-2h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H36O7 (400.2461)

(1s,3r,3as,4as,5r,7ar,8r,8as)-8a-hydroxy-3,5,8-trimethyl-3-[2-(3-methylfuran-2-yl)ethyl]-1-(2-methylprop-1-en-1-yl)-octahydroindeno[5,6-c]furan-4-one

C25H36O4 (400.2613)

4-[(2r,6r)-6-hydroxy-5-[(3e)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]-3,6-dihydro-2h-pyran-2-yl]-5h-furan-2-one

C25H36O4 (400.2613)

(9'e)-15'-hydroxy-3,3',15'-trimethyl-5-(2-methylprop-1-en-1-yl)-12'-oxaspiro[oxolane-2,6'-tetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadecan]-9'-en-11'-one

C25H36O4 (400.2613)

1β-d-glucopyranosyloxy-6α-hydroxy-eudesman-4(15)-ene

C21H36O7 (400.2461)

{"Ingredient_id": "HBIN002393","Ingredient_name": "1\u03b2-d-glucopyranosyloxy-6\u03b1-hydroxy-eudesman-4(15)-ene","Alias": "NA","Ingredient_formula": "C21H36O7","Ingredient_Smile": "CC(C)C1CCC2(C(CCC(=C)C2C1O)OC3C(C(C(C(O3)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8691","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

atractyloside c

C21H36O7 (400.2461)

{"Ingredient_id": "HBIN017303","Ingredient_name": "atractyloside c","Alias": "NA","Ingredient_formula": "C21H36O7","Ingredient_Smile": "CC12CCC(CC1C(=C)CC(C2)O)C(C)(C)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "400.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14420","TCMID_id": "1976","TCMSP_id": "NA","TCM_ID_id": "6491","PubChem_id": "101831401","DrugBank_id": "NA"}